DBVT DBV Technologies SA

Price (delayed)

$12.17

Market cap

$720.61M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.5

Enterprise value

$553.41M

?
Relative Growth: Rel. Growth: 44
Relative Strength: Rel. Strength: 20
Relative Valuation: Rel. Valuation: 1
Relative Profitability: Rel. Profitability: 21

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. The company provides Diallertest Milk, a diagnostic product for the detection of cow’s ...

Highlights
DBV Technologies's EPS has increased by 37% YoY and by 21% QoQ
DBV Technologies's equity has surged by 86% YoY but it has decreased by 23% QoQ
The quick ratio has soared by 54% YoY but it has contracted by 27% from the previous quarter
DBV Technologies's net income has decreased by 44% YoY and by 5% QoQ
DBV Technologies's debt has increased by 26% from the previous quarter

Key stats

What are the main financial stats of DBVT

DBVT stock price

How has the DBV Technologies stock price performed over time
Intraday
-3.64%
1 week
3.22%
1 month
-16.36%
1 year
30.16%
YTD
-36.52%
QTD
-25.79%

Financial performance

How have DBV Technologies's revenue and profit performed over time
Revenue
$5.02M
Gross profit
$5.02M
Operating income
-$177.73M
Net income
-$175.99M
Gross margin
100%
Net margin
-3,506.5%
DBV Technologies's operating income has decreased by 46% YoY and by 6% from the previous quarter
DBV Technologies's net income has decreased by 44% YoY and by 5% QoQ
The revenue is up by 29% year-on-year but it has declined by 14% since the previous quarter
DBV Technologies's gross profit has increased by 29% YoY but it has decreased by 14% QoQ

Price vs fundamentals

How does DBVT's price correlate with its fundamentals

Growth

What is DBV Technologies's growth rate over time

Valuation

What is DBV Technologies stock price valuation
P/E
N/A
P/B
4.49
P/S
210.25
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
110.26
DBV Technologies's EPS has increased by 37% YoY and by 21% QoQ
DBV Technologies's equity has surged by 86% YoY but it has decreased by 23% QoQ
DBVT's P/B is 12% below its last 4 quarters average of 5.3 and 2.9% below its 5-year quarterly average of 4.8
DBVT's P/S is 172% above its 5-year quarterly average of 80.2 and 19% above its last 4 quarters average of 183.7
The revenue is up by 29% year-on-year but it has declined by 14% since the previous quarter

Efficiency

How efficient is DBV Technologies business performance
DBV Technologies's ROE has soared by 58% YoY and by 8% from the previous quarter
DBV Technologies's ROA has increased by 39% YoY and by 5% from the previous quarter
DBV Technologies's return on sales has decreased by 22% QoQ and by 11% YoY

Dividends

What is DBVT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DBVT.

Financial health

How did DBV Technologies financials performed over time
DBV Technologies's total assets has surged by 56% YoY but it has decreased by 16% QoQ
The quick ratio has soared by 54% YoY but it has contracted by 27% from the previous quarter
DBV Technologies's debt is 95% less than its equity
DBV Technologies's equity has surged by 86% YoY but it has decreased by 23% QoQ
The debt to equity has soared by 67% from the previous quarter but it has contracted by 44% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.